If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Janice Mehnert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • CANCER CENTER SUPPORT GRANT

    Kane, M., Zong, W., Mehnert, J., Manne, S., Delnevo, C., Shen, Z., Ganesan, S., Foran, D., Liu, C., Laskin, D., Shih, W., Aisner, J., Lattime, E., Haffty, B., Bertino, J., August, D., August, D., Laskin, D., Shih, W., Rabinowitz, J., Zheng, S., Sant'Angelo, D. B., Tanzer, L. L., Gallo, J., Leibowitz, M., Chin, K. V., Ravikumar, T., Hait, W., Dipaola, R., Libutti, S. K., Kinzy, T. G., Spaulding, H., Amenta, P., Denicola, G., Shen, M. M., Kinzy, T. G., Notterman, D., Amenta, P. S., Rubin, E. H., Cunningham, R. S. & Saunders, T.

    National Institutes of Health

    3/1/972/29/24

    Rutgers, The State University

    Project: Research project

  • Research Output

    • 2282 Citations
    • 26 h-Index
    • 55 Article
    • 7 Review article
    • 3 Comment/debate
    • 2 Chapter

    A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

    Stein, M. N., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J. M., Jun 1 2020, In : Investigational New Drugs. 38, 3, p. 855-865 11 p.

    Rutgers, The State University

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Avelumab in patients with previously treated metastatic Merkel cell carcinoma: Long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

    D'Angelo, S. P., Bhatia, S., Brohl, A. S., Hamid, O., Mehnert, J. M., Terheyden, P., Shih, K. C., Brownell, I., Lebbé, C., Lewis, K. D., Linette, G. P., Milella, M., Georges, S., Shah, P., Ellers-Lenz, B., Bajars, M., Güzel, G. & Nghiem, P. T., May 15 2020, In : Journal for ImmunoTherapy of Cancer. 8, 1, e000674.

    Rutgers, The State University

    Research output: Contribution to journalArticle

    Open Access
  • Biomarkers for Response to Immune Checkpoint Blockade

    Ganesan, S. & Mehnert, J., Mar 4 2020, In : Annual Review of Cancer Biology. 4, p. 331-351 21 p.

    Rutgers, The State University

    Research output: Contribution to journalReview article

    Open Access
  • High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

    Silk, A. W., Kaufman, H. L., Curti, B., Mehnert, J. M., Margolin, K., McDermott, D., Clark, J., Newman, J., Bommareddy, P. K., Denzin, L., Najmi, S., Haider, A., Shih, W. & Kane, M. P., Jan 10 2020, In : Frontiers in Oncology. 9, 1483.

    Rutgers, The State University

    Research output: Contribution to journalArticle

    Open Access
  • Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

    Chung, H. C., Piha-Paul, S. A., Lopez-Martin, J., Schellens, J. H. M., Kao, S., Miller, W. H., Delord, J. P., Gao, B., Planchard, D., Gottfried, M., Zer, A., Jalal, S. I., Penel, N., Mehnert, J. M., Matos, I., Bennouna, J., Kim, D. W., Xu, L., Krishnan, S., Norwood, K. & 1 others, Ott, P. A., Apr 2020, In : Journal of Thoracic Oncology. 15, 4, p. 618-627 10 p.

    Rutgers, The State University

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations